Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aurobindo Pharma Ltd.

www.aurobindo.com

Latest From Aurobindo Pharma Ltd.

After Hiccups, Astellas’s Mirabegron On Course For Indian Debut?

Astellas’s overactive bladder drug mirabegron, which previously failed to pass muster in India, has now been cleared by an expert panel in the country, though competition appears to be building up alongside.

Research & Development Approvals

PTAB Tosses Two More Humira Patents; Will Supreme Court Eliminate IPR Proceeding?

Patent Trial and Appeal Board rules for Coherus in its challenge of Humira patents and takes up review of Cialis patent. US high court to consider constitutionality of inter partes review proceeding.

Intellectual Property Legal Issues

Keeping Track: Oncology Announcements, Priority Review Vouchers Continue To Pile Up

The latest drug development news and US FDA highlights from our Performance Tracker.

Complete Response Letters Drug Review

Acorda Defeats Kyle Bass, Now Awaits Ruling In Ampyra ANDA Litigation

Patent Trial and Appeal Board upheld validity of four Acorda patents; district court judge to issue decision on five patents. Victory would block generic competition until 2025.

Policy Legal Issues
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Aurobindo Pharma Ltd.
  • Senior Management
  • N Govindarajan, Mng. Dir.
  • Contact Info
  • Aurobindo Pharma Ltd.
    Phone: (91) 40 6672 5000
    WaterMark Bldg., Level 1
    Plot #11,Surv#9
    Hyderabad, 500 084
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register